{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:55:38Z","timestamp":1792133738450,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40123-025-01134-x","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:25:25Z","timestamp":1744082725000},"page":"1219-1235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Five-Year Outcomes of iStent inject Implantation With or Without Phacoemulsification in Eyes with Open-Angle Glaucoma"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-738X","authenticated-orcid":false,"given":"Ricardo Augusto Paletta","family":"Guedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Marcelo","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Maria Paletta","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Augusto Guedes","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Chaoubah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1134_CR1","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021; 9:e144-e160."},{"key":"1134_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"1134_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.amjopharm.2007.05.004","volume":"5","author":"MJ Bhosle","year":"2007","unstructured":"Bhosle MJ, Reardon G, Camacho FT, et al. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. Am J Geriatr Pharmacother. 2007;5:100\u201311.","journal-title":"Am J Geriatr Pharmacother"},{"key":"1134_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","volume":"158","author":"MV Boland","year":"2013","unstructured":"Boland MV, Ervin AM, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2013;158:271\u20139.","journal-title":"Ann Intern Med"},{"key":"1134_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","volume":"45","author":"X Zhang","year":"2019","unstructured":"Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019;45:11\u20138.","journal-title":"Eye Contact Lens"},{"key":"1134_CR6","first-page":"1","volume":"10","author":"JE Ord\u00f3\u00f1ez","year":"2018","unstructured":"Ord\u00f3\u00f1ez JE, Ord\u00f3\u00f1ez A, Osorio UM. Cost-effectiveness analysis of iStent\u00ae trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Curr Med Res Opin. 2018;10:1\u201312.","journal-title":"Curr Med Res Opin"},{"key":"1134_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/13696998.2019.1572013","volume":"22","author":"V Patel","year":"2019","unstructured":"Patel V, Ahmed I, Podbielski D, et al. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J Med Econ. 2019;22:390\u2013401.","journal-title":"J Med Econ"},{"issue":"Suppl 1","key":"1134_CR8","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","volume":"53","author":"GF Schwartz","year":"2008","unstructured":"Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl 1):S57\u201368.","journal-title":"Surv Ophthalmol"},{"key":"1134_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CM Olthoff","year":"2005","unstructured":"Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112:953\u201361.","journal-title":"Ophthalmology"},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598\u2013606.","journal-title":"Am J Ophthalmol"},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/09286586.2021.1955391","volume":"29","author":"SA Yang","year":"2022","unstructured":"Yang SA, Mitchell WG, Hall N, et al. Usage patterns of minimally invasive glaucoma surgery (MIGS) differ by glaucoma type: IRIS registry analysis 2013\u20132018. Ophthalmic Epidemiol. 2022;29:443\u201351.","journal-title":"Ophthalmic Epidemiol"},{"key":"1134_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/OPTH.S152268","volume":"12","author":"LJ Katz","year":"2018","unstructured":"Katz LJ, Erb C, Carceller GA. Long-term tirated IOP control with one, two or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes. Clin Ophthalmol. 2018;12:255\u201362.","journal-title":"Clin Ophthalmol"},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jcrs.2012.07.017","volume":"38","author":"GW Belovay","year":"2012","unstructured":"Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed II. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38:1911\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"1134_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-0035-1545798","volume":"232","author":"M El Wardani","year":"2015","unstructured":"El Wardani M, Bergin C, Achache F, Sharkawi E. Evaluating the trabecular micro-bypass stent combined with phacoemulsification compared to phacoemulsification alone. Klin Monatsbl Augenheilkd. 2015;232:442\u20135.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1134_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40123-019-0166-x","volume":"8","author":"RAP Guedes","year":"2019","unstructured":"Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. Intermediate results of iStent\u00ae or iStent\u00ae inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther. 2019;8:87\u2013100.","journal-title":"Ophthalmol Ther"},{"key":"1134_CR16","first-page":"8671","volume":"7","author":"ML Zhang","year":"2015","unstructured":"Zhang ML, Hirunyachote P, Jampel H. Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma. Cochrane Database Syst Rev. 2015;7:8671.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1134_CR17","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/OPTH.S422415","volume":"1","author":"D Laroche","year":"2023","unstructured":"Laroche D, Madu CT. Preventing blindness with early cataract surgery and micro-invasive glaucoma surgery in patients over 50: guidance for patients, physicians and world governments in dealing with glaucoma. Clin Ophthalmol. 2023;1(7):2929\u201338.","journal-title":"Clin Ophthalmol"},{"key":"1134_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ogla.2021.09.006","volume":"5","author":"S Sood","year":"2022","unstructured":"Sood S, Heilenbach N, Sanchez V, et al. Cost-effectiveness analysis of minimally invasive trabecular meshwork stents with phacoemulsification. Ophthalmol Glaucoma. 2022;5:284\u201396.","journal-title":"Ophthalmol Glaucoma"},{"key":"1134_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ogla.2019.11.009","volume":"3","author":"IIK Ahmed","year":"2020","unstructured":"Ahmed IIK, Podbielski DW, Patel V, et al. A Canadian cost-utility analysis of 2 trabecular microbypass stents at time of cataract surgery in patients with mild to moderate open-angle glaucoma. Ophthalmol Glaucoma. 2020;3:103\u201313.","journal-title":"Ophthalmol Glaucoma"},{"key":"1134_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. iStent\u00ae inject Study Group. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126:811\u201321.","journal-title":"Ophthalmology"},{"key":"1134_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ogla.2024.02.004","volume":"7","author":"JC Fan Gaskin","year":"2024","unstructured":"Fan Gaskin JC, Bigirimana D, Kong GYX, et al. Glaucoma Investigation and Research Unit, Royal Victorian Eye and Ear Hospital. Prospective, randomized controlled trial of cataract surgery vs combined cataract surgery with insertion of iStent\u00ae inject. Ophthalmol Glaucoma. 2024;7:326\u201334.","journal-title":"Ophthalmol Glaucoma."},{"issue":"3","key":"1134_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/IJG.0000000000001716","volume":"30","author":"A Salimi","year":"2021","unstructured":"Salimi A, Watt H, Harasymowycz P. Three-year outcomes of second-generation trabecular micro-bypass stents (iStent\u00ae inject) with phacoemulsification in various glaucoma subtypes and severities. J Glaucoma. 2021;30(3):266\u201375.","journal-title":"J Glaucoma"},{"issue":"16","key":"1134_CR23","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.2147\/OPTH.S373290","volume":"1","author":"C Clement","year":"2022","unstructured":"Clement C, Howes F, Ioannidis A, Shiu M, Manning D, Lusthaus JA, Skalicky SE, Goodwin TW. Multicenter effectiveness and disease stability through 3 years after iStent\u00aetrabecular micro-bypass with phacoemulsification in glaucoma and ocular hypertension. Clin Ophthalmol. 2022;1(16):2955\u201368.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1134_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12325-024-02788-y","volume":"41","author":"FH Hengerer","year":"2024","unstructured":"Hengerer FH, Auffarth GU, Conrad-Hengerer I. 7-year efficacy and safety of iStent\u00ae inject trabecular micro-bypass in combined and standalone usage. Adv Ther. 2024;41(4):1481\u201395.","journal-title":"Adv Ther"},{"key":"1134_CR25","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish RK II, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993."},{"key":"1134_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.007","volume":"229","author":"TW Samuelson","year":"2021","unstructured":"Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, McSorley D, Katz LJ. Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject pivotal trial. Am J Ophthalmol. 2021;229:220\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1134_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2020;127(4):477\u201383.","journal-title":"Ophthalmology"},{"issue":"4","key":"1134_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5301\/EJO.2010.6112","volume":"21","author":"GC Rossi","year":"2011","unstructured":"Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410\u20134.","journal-title":"Eur J Ophthalmol"},{"key":"1134_CR29","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.2147\/OPTH.S439457","volume":"17","author":"S Bedrood","year":"2023","unstructured":"Bedrood S, Berdahl J, Sheybani A, Singh IP. Alternatives to topical glaucoma medication for glaucoma management. Clin Ophthalmol. 2023;17:3899\u2013913.","journal-title":"Clin Ophthalmol"},{"key":"1134_CR30","first-page":"986","volume":"15","author":"S Kamat","year":"2024","unstructured":"Kamat S, Baudouin C, Shah M, Radcliffe N. Long-term chronic drop therapy vs intracameral procedural pharmaceuticals for glaucoma: what does the evidence support? J Clin Exp Ophthalmol. 2024;15:986.","journal-title":"J Clin Exp Ophthalmol."},{"key":"1134_CR31","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s40123-023-00831-9","volume":"12","author":"NM Radcliffe","year":"2023","unstructured":"Radcliffe NM, Shah M, Samuelson TW. Challenging the \u201ctopical medications-first\u201d approach to glaucoma: a treatment paradigm in evolution. Ophthalmol Ther. 2023;12:2823\u201339.","journal-title":"Ophthalmol Ther"},{"key":"1134_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/j.jcrs.0000000000001537","volume":"50","author":"JM Micheletti","year":"2024","unstructured":"Micheletti JM, Brink M, Brubaker JW, et al. Standalone interventional glaucoma: evolution from the combination-cataract paradigm. J Cataract Refract Surg. 2024;50:1284\u201390.","journal-title":"J Cataract Refract Surg"},{"key":"1134_CR33","first-page":"251584142412874","volume":"16","author":"T De Francesco","year":"2024","unstructured":"De Francesco T, Bacharach J, Smith O, Shah M. Early diagnostics and interventional glaucoma. Ther Adv Ophthalmol. 2024;16:25158414241287430.","journal-title":"Ther Adv Ophthalmol"},{"key":"1134_CR34","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s40123-024-01041-7","volume":"13","author":"A Yadgarov","year":"2024","unstructured":"Yadgarov A, Provencher L, Shafer B, Funke C. Adopting interventional glaucoma via sustained-release therapies: the wide-ranging impact of procedural pharmaceuticals in ophthalmology. Ophthalmol Ther. 2024;13:2825\u201338.","journal-title":"Ophthalmol Ther"},{"key":"1134_CR35","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.2147\/OPTH.S491287","volume":"18","author":"LJ Katz","year":"2024","unstructured":"Katz LJ, Myers JS, Herndon LW, et al. Interventional glaucoma: improving the patient-provider educational exchange. Clin Ophthalmol. 2024;18:3365\u201374.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"1134_CR36","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308\u201316.","journal-title":"Ophthalmology"},{"issue":"4","key":"1134_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12325-016-0302-0","volume":"33","author":"AGP Konstas","year":"2016","unstructured":"Konstas AGP, Quaranta L, Bozkurt B, et al. 24-h efficacy of glaucoma treatment options. Adv Ther. 2016;33(4):481\u2013517.","journal-title":"Adv Ther"},{"key":"1134_CR38","doi-asserted-by":"publisher","first-page":"9890831","DOI":"10.1155\/2019\/9890831","volume":"2019","author":"C Posarelli","year":"2019","unstructured":"Posarelli C, Ortenzio P, Ferreras A, et al. Twenty-four-hour contact lens sensor monitoring of aqueous humor dynamics in surgically or medically treated glaucoma patients. J Ophthalmol. 2019;2019:9890831.","journal-title":"J Ophthalmol"},{"issue":"4","key":"1134_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/jop.2011.0159","volume":"29","author":"GC Rossi","year":"2013","unstructured":"Rossi GC, Pasinetti GM, Scudeller L, Bianchi PE. Ocular surface disease and glaucoma: how to evaluate impact on quality of life. J Ocul Pharmacol Ther. 2013;29(4):390\u20134.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"1134_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40123-021-00412-8","volume":"10","author":"S Rho","year":"2021","unstructured":"Rho S, Lim SH. Clinical outcomes after second-generation trabecular microbypass stents (iStent inject) with phacoemulsification in korean patients. Ophthalmol Ther. 2021;10(4):1105\u201317.","journal-title":"Ophthalmol Ther"},{"key":"1134_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40123-019-00208-x","volume":"8","author":"D Manning","year":"2019","unstructured":"Manning D. Real-world case series of iStent\u00ae or iStent inject trabecular micro-bypass stents combined with cataract surgery. Ophthalmol Ther. 2019;8:549\u201361.","journal-title":"Ophthalmol Ther"},{"key":"1134_CR42","doi-asserted-by":"publisher","first-page":"3182935","DOI":"10.1155\/2017\/3182935","volume":"2017","author":"DZ Chen","year":"2017","unstructured":"Chen DZ, Sng CCA. Safety and efficacy of microinvasive glaucoma surgery. J Ophthalmol. 2017;2017:3182935.","journal-title":"J Ophthalmol"},{"key":"1134_CR43","doi-asserted-by":"publisher","first-page":"1056573","DOI":"10.1155\/2016\/1056573","volume":"2016","author":"P Arriola-Villalobos","year":"2016","unstructured":"Arriola-Villalobos P, Martinez-de-la-Casa JM, Diaz-Valle D, Morales-Fernandez L, Fernandez-Perez C, Garcia-Feijoo J. Glaukos iStent inject trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study. J Ophthalmol. 2016;2016:1056573.","journal-title":"J Ophthalmol"},{"issue":"8","key":"1134_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00347-018-0824-8","volume":"116","author":"UP Best","year":"2019","unstructured":"Best UP, Domack H, Schmidt V, Khalifa M. Microinvasive glaucoma surgery-efficacy of trabecular stents in combined interventions: a clinical study on 65 eyes. Ophthalmologe. 2019;116(8):771\u20139.","journal-title":"Ophthalmologe"},{"issue":"3","key":"1134_CR45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s12325-021-02039-4","volume":"39","author":"FH Hengerer","year":"2022","unstructured":"Hengerer FH, Auffarth GU, Conrad-Hengerer I. iStent inject trabecular micro-bypass with or without cataract surgery yields sustained 5-year glaucoma control. Adv Ther. 2022;39(3):1417\u201331.","journal-title":"Adv Ther"},{"issue":"2","key":"1134_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40123-018-0152-8","volume":"7","author":"FH Hengerer","year":"2018","unstructured":"Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in various types of glaucoma. Ophthalmol Ther. 2018;7(2):405\u201315.","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"1134_CR47","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s12325-019-00984-9","volume":"36","author":"FH Hengerer","year":"2019","unstructured":"Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Second-generation trabecular micro-bypass stents as standalone treatment for glaucoma: a 36-month prospective study. Adv Ther. 2019;36(7):1606\u201317.","journal-title":"Adv Ther"},{"issue":"7","key":"1134_CR48","first-page":"1","volume":"10","author":"R Neuhann","year":"2020","unstructured":"Neuhann R, Neuhann T. Second-generation trabecular micro-bypass stent implantation: retrospective analysis after 12- and 24-month follow-up. Eye Vis (Lond). 2020;10(7):1.","journal-title":"Eye Vis (Lond)"},{"issue":"6","key":"1134_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/ceo.13763","volume":"48","author":"J Berdahl","year":"2020","unstructured":"Berdahl J, Voskanyan L, Myers JS, Katz LJ, Samuelson TW. iStent\u00ae inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes. Clin Exp Ophthalmol. 2020;48(6):767\u201374.","journal-title":"Clin Exp Ophthalmol"},{"key":"1134_CR50","first-page":"875","volume":"8","author":"AM Fea","year":"2014","unstructured":"Fea AM, Belda JI, Rekas M, et al. Prospective unmasked randomized evaluation of the iStent\u00ae inject\u00ae versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875\u201382.","journal-title":"Clin Ophthalmol"},{"key":"1134_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/OPTH.S235293","volume":"14","author":"R Lindstrom","year":"2020","unstructured":"Lindstrom R, Sarkisian SR, Lewis R, Hovanesian J, Voskanyan L. Four-year outcomes of two second-generation trabecular micro-bypass stents in patients with open-angle glaucoma on one medication. Clin Ophthalmol. 2020;14:71\u201380.","journal-title":"Clin Ophthalmol"},{"key":"1134_CR52","doi-asserted-by":"publisher","first-page":"112067212412722","DOI":"10.1177\/11206721241272224","volume":"6","author":"G Vizzari","year":"2024","unstructured":"Vizzari G, Ceruti P. Effectiveness and safety of iStent\u00ae inject as an interventional glaucoma approach for uncontrolled open-angle glaucoma. Eur J Ophthalmol. 2024;6:11206721241272224. https:\/\/doi.org\/10.1177\/11206721241272224.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"1134_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12325-014-0095-y","volume":"31","author":"L Voskanyan","year":"2014","unstructured":"Voskanyan L, Garcia-Feijoo J, Belda J, Fea A, J\u00fcnemann A, Baudouin C. Synergy Study Group. Prospective, unmasked evaluation of the iStent\u00ae inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31(2):189\u2013201.","journal-title":"Adv Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01134-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01134-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01134-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:04:11Z","timestamp":1747044251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01134-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01134-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ricardo Augusto Paletta Guedes: Abbvie (consultant, speaker); Alcon (consultant); Baush Lomb (consultant, speaker); Cristalia (consultant, speaker); Glaukos (consultant, speaker); OftaVision (consultant, speaker). Daniela Marcelo Gravina: None. Vanessa Maria Paletta Guedes: None. Daniel Augusto Guedes Moraes: None. Alfredo Chaoubah: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The local Institutional Review Board approved the study (Ethics in Research Committee under the number CAAE: 21327319.5.0000.5139), and all data accessed complied with relevant data protection and privacy regulations. The research methods comply with the Declaration of Helsinki. All patients gave informed consent prior to undergoing the procedure. Separate consent for data analysis was not needed due to the study\u2019s retrospective design and non-interventional review of medical records from the surgeon\u2019s existing practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}